Salmon D - Search Results

1

The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.

Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD; Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD. Mocroft A, et al. Among authors: d arminio monforte a, salmon d. Clin Infect Dis. 2013 Oct;57(7):1038-47. doi: 10.1093/cid/cit423. Epub 2013 Aug 6. Clin Infect Dis. 2013. PMID: 23921881 Free article.

2

[Causes of death in HIV-infected French drug users, 1995-2000].

Lewden C, Bonnet F, Bevilacqua S, Heripret L, May T, Morlat P, Jougla E, Dabis F, Chêne G, Salmon D; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine; Groupe "Mortalité 2000". Lewden C, et al. Among authors: salmon d. Ann Med Interne (Paris). 2002 Nov;153(7 Suppl):2S4-10. Ann Med Interne (Paris). 2002. PMID: 12518077 French.

3

Quantitation of cytomegalovirus (CMV) DNA by real-time PCR for occurrence of CMV disease in HIV-infected patients receiving highly active antiretroviral therapy.

Gourlain K, Salmon D, Gault E, Leport C, Katlama C, Matheron S, Costagliola D, Mazeron MC, Fillet AM; Predivir Study Group; CMV AC11 Study Group. Gourlain K, et al. Among authors: salmon d. J Med Virol. 2003 Mar;69(3):401-7. doi: 10.1002/jmv.10303. J Med Virol. 2003. PMID: 12526052

4

Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chêne G, Morlat P. Bonnet F, et al. Among authors: salmon d. Cancer. 2004 Jul 15;101(2):317-24. doi: 10.1002/cncr.20354. Cancer. 2004. PMID: 15241829 Free article.

5

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, Héripret L, Costagliola D, May T, Chêne G; Mortality 2000 study group. Lewden C, et al. Among authors: salmon d. Int J Epidemiol. 2005 Feb;34(1):121-30. doi: 10.1093/ije/dyh307. Epub 2004 Nov 23. Int J Epidemiol. 2005. PMID: 15561752

6

Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohort.

Duval X, Mentré F, Lamotte C, Chêne G, Spire B, Dellamonica P, Panhard X, Salmon D, Raffi F, Peytavin G, Leport C; APROCO Study Group. Duval X, et al. Among authors: salmon d. Ther Drug Monit. 2005 Feb;27(1):63-70. doi: 10.1097/00007691-200502000-00013. Ther Drug Monit. 2005. PMID: 15665749 Clinical Trial.

7

Impact of newly available drugs on clinical progression in patients with virological failure after exposure to three classes of antiretrovirals.

Costagliola D, Potard V, Duvivier C, Pradier C, Dupont C, Salmon D, Duval X; French Hospital Database on HIV. Costagliola D, et al. Among authors: salmon d. Antivir Ther. 2005;10(4):563-73. Antivir Ther. 2005. PMID: 16038483

8

Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France.

Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, Costagliola D, Salmon D, Chêne G, Morlat P; Mortalité 2000 Study Group. Bonnet F, et al. Among authors: salmon d. Scand J Infect Dis. 2005;37(6-7):482-7. doi: 10.1080/00365540510035328. Scand J Infect Dis. 2005. PMID: 16089023

9

Therapeutic management of hepatitis and HIV infection in co-infected patients: results of a survey performed before the 2005 Consensus Conference.

Salmon D, Robain M, Rockstroh JK, Benhamou Y. Salmon D, et al. J Hepatol. 2006;44(1 Suppl):S2-5. doi: 10.1016/j.jhep.2005.11.034. Epub 2005 Dec 5. J Hepatol. 2006. PMID: 16360970

10

Risk factors for osteonecrosis in HIV-infected patients: impact of treatment with combination antiretroviral therapy.

Mary-Krause M, Billaud E, Poizot-Martin I, Simon A, Dhiver C, Dupont C, Salmon D, Roudiere L, Costagliola D; Clinical Epidemiology Group of the French Hospital Database. Mary-Krause M, et al. Among authors: salmon d. AIDS. 2006 Aug 1;20(12):1627-35. doi: 10.1097/01.aids.0000238409.90571.02. AIDS. 2006. PMID: 16868444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,291 results

Search Page

Filters